Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H14ClN3O4S3 |
Molecular Weight | 383.895 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=CC2=C(NC(CSCC=C)NS2(=O)=O)C=C1Cl
InChI
InChIKey=VGLGVJVUHYTIIU-UHFFFAOYSA-N
InChI=1S/C11H14ClN3O4S3/c1-2-3-20-6-11-14-8-4-7(12)9(21(13,16)17)5-10(8)22(18,19)15-11/h2,4-5,11,14-15H,1,3,6H2,(H2,13,16,17)
Molecular Formula | C11H14ClN3O4S3 |
Molecular Weight | 383.895 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of pH and the presence of micelles on the resolution of diuretics by reversed-phase liquid chromatography. | 2004 Jan 2 |
|
Mechanism of [m+h]+ formation in atmospheric pressure photoionization mass spectrometry: identification of propionitrile in acetonitrile with high mass accuracy measurement and tandem mass spectrometry and evidence for its involvement in the protonation phenomenon. | 2008 Nov |
|
A case of brucellar spondylodiscitis involving the cervical spine. | 2009 |
|
Stability of selected chlorinated thiazide diuretics. | 2009 Feb 20 |
|
Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. | 2009 Mar 20 |
|
Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. | 2009 Sep 15 |
|
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. | 2010 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2191585
Aldactazine ( 25 mg spironolactone and 15 mg altizide, 1/day)
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:12:48 GMT 2023
by
admin
on
Fri Dec 15 16:12:48 GMT 2023
|
Record UNII |
GI8CB72B0D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC03EA04
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
||
|
NCI_THESAURUS |
C49185
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
||
|
WHO-ATC |
C03EA04
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB05379MIG
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
m1584
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | Merck Index | ||
|
2122
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL599870
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
1382
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
17599
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | RxNorm | ||
|
140
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
DTXSID3045857
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
5588-16-9
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
226-994-8
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
GI8CB72B0D
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
757786
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
100000092140
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
C80838
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
C006480
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY | |||
|
ALTIZIDE
Created by
admin on Fri Dec 15 16:12:48 GMT 2023 , Edited by admin on Fri Dec 15 16:12:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|